Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens

Neurochemical Research

Volumn 40, Issue 11, 2015, Pages 2167-2176

  Frederikse, Peter H ^a   Nandanoor, Anoop ^a   Kasinathan, Chinnaswamy ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Fragile X mental retardation protein; Fragile X syndrome; Gene expression; Lens; Model system; Neurodevelopment

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR 1; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BETA 3; 4 AMINOBUTYRIC ACID RECEPTOR DELTA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; F ACTIN; FRAGILE X MENTAL RETARDATION PROTEIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; METABOTROPIC RECEPTOR 5; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN TYROSINE PHOSPHATASE; STRIATAL ENRICHED PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; DLGH4 PROTEIN, MOUSE; GABAERGIC RECEPTOR AFFECTING AGENT; GUANYLATE KINASE; MEMBRANE PROTEIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CELL DIFFERENTIATION; CELL ELONGATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DENDRITE; DENDRITIC SPINE; DEVELOPMENTAL STAGE; EXPERIMENTAL CHICKEN; EXPERIMENTAL RABBIT; FRAGILE X SYNDROME; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LENS FIBER; LENS NUCLEUS; MOUSE; NERVE CELL; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; YOUNG ADULT; ALTERNATIVE RNA SPLICING; ANIMAL; C57BL MOUSE; CHICKEN; GENETICS; LENS; METABOLISM; RABBIT;

ALTERNATIVE SPLICING; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CHICKENS; DENDRITES; FRAGILE X MENTAL RETARDATION PROTEIN; GABA AGENTS; GUANYLATE KINASE; LENS, CRYSTALLINE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; RABBITS; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, GABA;

EID: 84947021201     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1702-2     Document Type: Article

References (69)

1. Fernandez E, Rajan N, Bagni C (2013) The FMRP regulon: from targets to disease convergence. Front Neurosci 7:191
2. Westmark CJ, Malter JS (2007) FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 5:e52
3. Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK (2011) Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology 76:1344–1352
4. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247–261
5. Darnell JC, Mostovetsky O, Darnell RB (2005) FMRP RNA targets: identification and validation. Genes Brain Behav 4:341–349
6. Ascano M Jr, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, Langlois C, Munschauer M, Dewell S, Hafner M, Williams Z, Ohler U, Tuschl T (2012) FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492:382–386
7. Pasciuto E, Bagni C (2014) SnapShot: FMRP mRNA targets and diseases. Cell 158:1446–1441
8. Hughes V http://sfari.org/news-and-opinion/news/2013/hunt-for-targets-of-fragile-x-protein-proves-perplexing
9. Gessert S, Bugner V, Tecza A, Pinker M, Kuhl M (2010) FMR1/FXR1 and the miRNA pathway are required for eye and neural crest development. Dev Biol 341:222–235
10. Wan L, Dockendorff TC, Jongens TA, Dreyfuss G (2000) Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol Cell Biol 20:8536–8547
11. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M (1993) Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3:36–43
12. Lo WK, Wen XJ, Zhou CJ (2003) Microtubule configuration and membranous vesicle transport in elongating fiber cells of the rat lens. Exp Eye Res 77:615–626
13. Zhou CJ, Lo WK (2003) Association of clathrin, AP-2 adaptor and actin cytoskeleton with developing interlocking membrane domains of lens fibre cells. Exp Eye Res 77:423–432
14. Frederikse PH, Kasinathan C (2015) Lens GABA receptors are a target of GABA-related agonists that mitigate experimental myopia. Med Hypotheses 84:589–592
15. Frederikse PH, Nandanoor A, Kasinathan C (2015) Moonlighting’ GAPDH protein localizes with AMPA receptor GluA2 and L1 axonal cell adhesion molecule at fiber cell borders in the lens. Curr Eye Res 23:1–9
16. Frederikse PH, Nandanoor A, Kasinathan C (2014) PTBP-dependent PSD-95 and CamKIIα alternative splicing in the lens. Mol Vis 20:1660–1667
17. Farooq M, Kaswala RH, Kleiman NJ, Kasinathan C, Frederikse PH (2012) GluA2 AMPA glutamate receptor subunit exhibits codon 607 Q/R RNA editing in the lens. Biochem Biophys Res Commun 418:273–277
18. Bhattacharya M, Nandanoor A, Osman M, Kasinathan C, Frederikse PH (2014) NMDA glutamate receptor NR1, NR2A and NR2B Expression and NR2B Tyr-1472 phosphorylation in the lens. Neurochem Res 39:1825–1832
19. Frederikse PH, Kasinathan C, Kleiman NJ (2012) Parallels between neuron and lens fiber cell structure and molecular regulatory networks. Dev Biol 368:255–260
20. Kwakowsky A, Schwirtlich M, Kooy F, Abraham I, Mate Z, Katarova Z, Szabo G (2008) GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality. Dev Dyn 237:3830–3841
21. Kwakowsky A, Schwirtlich M, Zhang Q, Eisenstat DD, Erdelyi F, Baranyi M, Katarova ZD, Szabo G (2007) GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5. Dev Dyn 236:3532–3544
22. Frederikse PH, Donnelly R, Partyka LM (2006) miRNA and Dicer in the mammalian lens: expression of brain-specific miRNAs in the lens. Histochem Cell Biol 126:1–8
23. Bitel CL, Perrone-Bizzozero NI, Frederikse PH (2010) HuB/C/D, nPTB, REST4, and miR-124 regulators of neuronal cell identity are also utilized in the lens. Mol Vis 16:2301–2316
24. Frederikse PH, Yun E, Kao HT, Zigler JS Jr, Sun Q, Qazi AS (2004) Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation. Mol Vis 10:794–804
25. Frederikse PH, Garland D, Zigler JS Jr, Piatigorsky J (1996) Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J Biol Chem 271:10169–10174
26. Fatemi SH, Folsom TD, Kneeland RE, Liesch SB (2011) Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anat Rec (Hoboken) 294:1635–1645
27. Dolen G, Bear MF (2008) Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J Physiol 586:1503–1508
28. Gandhi RM, Kogan CS, Messier C (2014) 2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice. Front Cell Neurosci 8:70
29. Braat S, Kooy RF (2015) Insights into GABAergic system deficits in fragile X syndrome lead to clinical trials. Neuropharmacology 88:48–54
30. D’Hulst C, De Geest N, Reeve SP, Van Dam D, De Deyn PP, Hassan BA, Kooy RF (2006) Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res 1121:238–245
31. D’Hulst C, Heulens I, Brouwer JR, Willemsen R, De Geest N, Reeve SP, De Deyn PP, Hassan BA, Kooy RF (2009) Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS). Brain Res 1253:176–183
32. Laurie DJ, Wisden W, Seeburg PH (1992) The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12:4151–4172
33. Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL (1997) GABAA, NMDA and AMPA receptors: a developmentally regulated ‘menage a trois’. Trends Neurosci 20:523–529
34. Sernagor E, Chabrol F, Bony G, Cancedda L (2010) GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems. Front Cell Neurosci 4:11
35. He Q, Nomura T, Xu J, Contractor A (2014) The developmental switch in GABA polarity is delayed in fragile X mice. J Neurosci 34:446–450
36. Gurkan CK, Hagerman RJ (2012) Targeted treatments in autism and fragile X syndrome. Res Autism Spectr Disord 6:1311–1320
37. Hagerman R, Lauterborn J, Au J, Berry-Kravis E (2012) Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ 54:297–335
38. Wang LW, Berry-Kravis E, Hagerman RJ (2010) Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7:264–274
39. Schmid KL, Strasberg G, Rayner CL, Hartfield PJ (2013) The effects and interactions of GABAergic and dopaminergic agents in the prevention of form deprivation myopia by brief periods of normal vision. Exp Eye Res 110:88–95
40. Stone RA, Liu J, Sugimoto R, Capehart C, Zhu X, Pendrak K (2003) GABA, experimental myopia, and ocular growth in chick. Invest Ophthalmol Vis Sci 44:3933–3946
41. Chebib M, Hinton T, Schmid KL, Brinkworth D, Qian H, Matos S, Kim HL, Abdel-Halim H, Kumar RJ, Johnston GA, Hanrahan JR (2009) Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory. J Pharmacol Exp Ther 328:448–457
42. Christian PG, Harkin DG, Schmid KL (2014) GABAergic agents modify the response of chick scleral fibroblasts to myopic and hyperopic eye cup tissues. Curr Eye Res 39:172–187
43. Davidovic L, Navratil V, Bonaccorso CM, Catania MV, Bardoni B, Dumas ME (2011) A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model. Genome Res 21:2190–2202
44. Zhu ZW, Xu Q, Zhao ZY, Gu WZ, Wu DW (2011) Spatiotemporal expression of PSD-95 in Fmr1 knockout mice brain. Neuropathology 31:223–229
45. Zheng S, Gray EE, Chawla G, Porse BT, O’Dell TJ, Black DL (2012) PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nat Neurosci 15:381–388 S381
46. Okamura A, Goto S, Nishi T, Yamada K, Yoshikawa M, Ushio Y (1997) Postnatal ontogeny of striatal-enriched protein tyrosine phosphatase (STEP) in rat striatum. Exp Neurol 145:228–234
47. Tang K, Liu C, Kuluz J, Hu B (2004) Alterations of CaMKII after hypoxia-ischemia during brain development. J Neurochem 91:429–437
48. Curras MC, Dao J (1998) Developmental plasticity of NR1 and NR2B subunit expression in the supraoptic nucleus of the rat hypothalamus. Brain Res Dev Brain Res 109:1–12
49. Rodenas-Ruano A, Chavez AE, Cossio MJ, Castillo PE, Zukin RS (2012) REST-dependent epigenetic remodeling promotes the developmental switch in synaptic NMDA receptors. Nat Neurosci 15:1382–1390
50. Medvedev NI, Rodriguez-Arellano JJ, Popov VI, Davies HA, Tigaret CM, Schoepfer R, Stewart MG (2008) The glutamate receptor 2 subunit controls post-synaptic density complexity and spine shape in the dentate gyrus. Eur J Neurosci 27:315–325
51. Conaco C, Otto S, Han JJ, Mandel G (2006) Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Nat Acad Sci USA 103:2422–2427
52. Makinae K, Kobayashi T, Shinkawa H, Sakagami H, Kondo H, Tashiro F, Miyazaki J, Obata K, Tamura S, Yanagawa Y (2000) Structure of the mouse glutamate decarboxylase 65 gene and its promoter: preferential expression of its promoter in the GABAergic neurons of transgenic mice. J Neurochem 75:1429–1437
53. Gupta SK, Gressens P, Mani S (2009) NRSF downregulation induces neuronal differentiation in mouse embryonic stem cells. Differentiation 77:19–28
54. Antar LN, Afroz R, Dictenberg JB, Carroll RC, Bassell GJ (2004) Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J Neurosci 24:2648–2655
55. Okamoto K, Narayanan R, Lee SH, Murata K, Hayashi Y (2007) The role of CaMKII as an F-actin-bundling protein crucial for maintenance of dendritic spine structure. Proc Natl Acad Sci USA 104:6418–6423
56. Pinal CS, Tobin AJ (1998) Uniqueness and redundancy in GABA production. Perspect Dev Neurobiol 5:109–118
57. Bersten DC, Wright JA, McCarthy PJ, Whitelaw ML (2014) Regulation of the neuronal transcription factor NPAS4 by REST and microRNAs. Biochim Biophys Acta 1839:13–24
58. Lin Y, Bloodgood BL, Hauser JL, Lapan AD, Koon AC, Kim TK, Hu LS, Malik AN, Greenberg ME (2008) Activity-dependent regulation of inhibitory synapse development by Npas4. Nature 455:1198–1204
59. Kaufmann WE, Moser HW (2000) Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 10:981–991
60. Levenga J, Willemsen R (2012) Perturbation of dendritic protrusions in intellectual disability. Prog Brain Res 197:153–168
61. Irwin SA, Galvez R, Greenough WT (2000) Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex 10:1038–1044
62. Pop AS, Levenga J, de Esch CE, Buijsen RA, Nieuwenhuizen IM, Li T, Isaacs A, Gasparini F, Oostra BA, Willemsen R (2014) Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant. Psychopharmacology 231:1227–1235
63. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, Tada T, Dolan BM, Sharp PA, Sheng M (2010) Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65:373–384
64. Makarev E, Spence JR, Del Rio-Tsonis K, Tsonis PA (2006) Identification of microRNAs and other small RNAs from the adult newt eye. Mol Vis 12:1386–1391
65. Westmark CJ (2014) The quest for fragile X biomarkers. Mol Cell Pediatr 1:e80488
66. Corrigan NM, Shaw DW, Estes AM, Richards TL, Munson J, Friedman SD, Dawson G, Artru AA, Dager SR (2013) Atypical developmental patterns of brain chemistry in children with autism spectrum disorder. JAMA Psychiatry 70:964–974
67. Kleinhans NM, Schweinsburg BC, Cohen DN, Muller RA, Courchesne E (2007) N-acetyl aspartate in autism spectrum disorders: regional effects and relationship to fMRI activation. Brain Res 1162:85–97
68. Kubas B, Kulak W, Sobaniec W, Tarasow E, Lebkowska U, Walecki J (2012) Metabolite alterations in autistic children: a 1H MR spectroscopy study. Adv Med Sci 57:152–156
69. Baslow MH, Yamada S (1997) Identification of N-acetylaspartate in the lens of the vertebrate eye: a new model for the investigation of the function of N-acetylated amino acids in vertebrates. Exp Eye Res 64:283–286